Discover 1,423 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,423
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
for
Grade 2 Meningioma, Intracranial Meningioma
Location: Cleveland OH, Mentor OH, Columbus OH, Detroit MI,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT03180268
Phase3, Recruiting
New
Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
for
Alcohol Use Disorder (AUD), Alcohol Related Liver Disease
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07824089
Recruiting
New
NIRAF-camera Versus Conventional Surgery in Preoperative Imaging Negative Primary Hyperparathyroidism
for
Primary Hyperparathyroidism
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07812649
Recruiting
New
Robotic Adrenalectomy With Versus Without Indocyanine Green Fluorescence Imaging
for
Adrenalectomy
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07813247
Recruiting
New
Effects of Non-invasive Brain Stimulation on Pain Avoidance Behavior in Chronic Pain Patients
for
Complex Regional Pain Syndrome (CRPS)
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07791966
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Evaluation of 4D Intracardiac Echocardiography (ICE) During Structural Heart and Electrophysiology Procedures
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for
Ovarian Cancer
Location: Cleveland OH, Charleston WV, York PA, Baltimore MD,
Sponsor: NX Development Corp
Sex: Female
Age: 18+
Code: NCT05804370
Phase3, Recruiting
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Cleveland OH, New York NY, Rochester MN,
Sponsor: GI Innovation, Inc.
Sex: All
Age: 18+
Code: NCT05824975
Phase1, Phase2, Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM